RT Journal Article
T1 Limosilactobacillus fermentum CECT5716: Mechanisms and Therapeutic Insights
A1 Rodríguez-Sojo, María Jesús
A1 Ruiz-Malagón, Antonio Jesús
A1 Rodríguez-Cabezas, María Elena
A1 Gálvez, Julio
A1 Rodríguez-Nogales, Alba
K1 Probiotic
K1 Limosilactobacillus fermentum CECT5716
K1 Immunomodulation
K1 Dysbiosis
K1 Mechanisms of action
K1 Gastrointestinal diseases
K1 Microbiota
K1 Probióticos
K1 Inmunomodulación
K1 Disbiosis
K1 Mecanismos moleculares de acción farmacológica
K1 Enfermedades gastrointestinales
K1 Microbiota
AB Probiotics microorganisms exert their health-associated activities through some of the following general actions: competitive exclusion, enhancement of intestinal barrier function, production of bacteriocins, improvement of altered microbiota, and modulation of the immune response. Among them, Limosilactobacillus fermentum CECT5716 has become one of the most promising probiotics and it has been described to possess potential beneficial effects on inflammatory processes and immunological alterations. Different studies, preclinical and clinical trials, have evidenced its anti-inflammatory and immunomodulatory properties and elucidated the precise mechanisms of action involved in its beneficial effects. Therefore, the aim of this review is to provide an updated overview of the effect on host health, mechanisms, and future therapeutic approaches.
PB MDPI AG
YR 2021
FD 2021-03-21
LK http://hdl.handle.net/10668/3463
UL http://hdl.handle.net/10668/3463
LA en
NO Rodríguez-Sojo MJ, Ruiz-Malagón AJ, Rodríguez-Cabezas ME, Gálvez J, Rodríguez-Nogales A. Limosilactobacillus fermentum CECT5716: Mechanisms and Therapeutic Insights. Nutrients. 2021;13(3):1016.
DS RISalud
RD Apr 8, 2025